Macquarie Group
TMDX icon

Macquarie Group’s Transmedics TMDX Stock Holding History

Macquarie Group’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-906,268
Closed -$102M – 1451
2025
Q3 		$102M Sell
906,268
-45,837
-5% -$5.37M 0.12% 220
2025
Q2 		$128M Sell
952,105
-163,491
-15% -$18M 0.16% 159
2025
Q1 		$75.1M Buy
1,115,596
+123,096
+12% +$8.47M 0.09% 309
2024
Q4 		$61.9M Buy
992,500
+96,389
+11% +$8.97M 0.08% 359
2024
Q3 		$141M Sell
896,111
-60,188
-6% -$9.27M 0.15% 178
2024
Q2 		$144M Sell
956,299
-341,420
-26% -$41M 0.17% 159
2024
Q1 		$96M Sell
1,297,719
-228,100
-15% -$18.8M 0.11% 247
2023
Q4 		$120M Sell
1,525,819
-185,032
-11% -$11.2M 0.14% 201
2023
Q3 		$93.7M Buy
1,710,851
+16,685
+1% +$1.2M 0.12% 226
2023
Q2 		$142M Sell
1,694,166
-51,191
-3% -$3.92M 0.16% 168
2023
Q1 		$132M Sell
1,745,357
-202,115
-10% -$14M 0.16% 173
2022
Q4 		$120M Buy
1,947,472
+197,273
+11% +$10.5M 0.14% 195
2022
Q3 		$73.1M Sell
1,750,199
-74,636
-4% -$3.25M 0.09% 308
2022
Q2 		$57.4M Sell
1,824,835
-251,901
-12% -$6.72M 0.06% 401
2022
Q1 		$55.9M Buy
2,076,736
+425,450
+26% +$7.62M 0.04% 488
2021
Q4 		$31.6M Buy
1,651,286
+27,070
+2% +$679K 0.03% 632
2021
Q3 		$53.7M Buy
1,624,216
+105,095
+7% +$3.21M 0.05% 500
2021
Q2 		$50.4M Buy
1,519,121
+550,627
+57% +$15.3M 0.04% 540
2021
Q1 		$40.2M Buy
968,494
+7,421
+0.8% +$228K 0.06% 379
2020
Q4 		$19.1M Buy
961,073
+216,212
+29% +$3.2M 0.03% 534
2020
Q3 		$10.3M Buy
744,861
+361,110
+94% +$6.19M 0.02% 644
2020
Q2 		$6.88M Buy
+383,751
New +$6M 0.01% 719

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Macquarie Group's TMDX Position: Q4 2025 in Review

Macquarie Group sold out of Transmedics (TMDX) in Q4 2025, closing a stake of 906,268 shares — an estimated $102M sold.

Macquarie Group first reported a position in TMDX in Q2 2020 and held it in 22 quarters. The position peaked at $144M in Q2 2024. 429 funds tracked by Wall St. Rank hold TMDX as of Q4 2025.

  • Macquarie Group reported no remaining Transmedics position as of Q4 2025 after selling out during the quarter.
  • Macquarie Group sold 906,268 Transmedics shares in Q4 2025, an estimated $102M.
  • Macquarie Group first reported a position in Transmedics in Q2 2020 and held it in 22 quarters.
  • Macquarie Group's Transmedics position peaked at $144M in Q2 2024.
  • 429 funds tracked by Wall St. Rank held Transmedics as of Q4 2025.

Based on Macquarie Group's 13F filing for Q4 2025, filed 13 Feb 2026.